Indian drugmakers Glenmark Pharmaceuticals, Sun Pharmaceutical Industries, and Zydus are recalling several medicines from ...

Drug makers Glenmark, Sun Pharma and Zydus are recalling products in the US for manufacturing issues, the US Food and Drug ...

Glenmark and Biocon, two pharmaceutical companies, are recalling certain medications in the US due to manufacturing issues. The USFDA reports Glenmark is recalling Chlorpromazine for impurity issues, ...

Glenmark's marketing portfolio as of December 2024 had 201 generic products authorised for distribution in the US. The ...

Glenmark, Sun Pharma, and Zydus are recalling products in the US due to manufacturing issues, according to the USFDA. Glenmark is recalling over 25 products due to CGMP deviations. Sun Pharma recalls ...

Michael Tappin KC, sitting as a deputy judge of the High Court, refused to grant AstraZeneca (“AZ”) an interim injunction ...

According to the US FDA website, the majority of these recalls were due to the drugs reaching their expiry date in March 2025 ...

Glenmark and Biocon are recalling products in the U.S. due to manufacturing issues. Glenmark is recalling 8,160 bottles of ...

(RTTNews) - Glenmark Pharmaceuticals Inc., USA ... bioequivalent and therapeutically equivalent to the reference listed drug, Vancomycin Hydrochloride for Injection USP, 750 mg/vial, 1.25 g ...

Glenmark and Biocon are recalling products in the US due to manufacturing issues. USFDA initiated Class II recalls for ...

India is the largest supplier of generic medicines with around 20% share in the global supply by manufacturing 60,000 ...

According to the USFDA, a Class II recall is issued when the use of or exposure to a violative product may cause temporary or ...